
Synergy Shield Coronary Stent 2.50 X 8 | REF H7493966608250
Boston Scientific Synergy Shield Coronary Stent, 2.50 mm x 8 mm (REF H7493966608250) for B2B medical device procurement.

The Terumo Ultimaster Nagomi Coronary Stent (REF DE-RS2518ASM) is a sirolimus-eluting coronary stent system in a 2.50 mm × 18 mm size, designed for percutaneous coronary intervention. It combines a thin-strut cobalt-chromium platform with an abluminal bioresorbable polymer coating intended to support controlled drug release and predictable vessel healing.
Key Features
- Drug: Sirolimus eluted from an abluminal bioresorbable PDLLA-PCL polymer coating
- Platform: Thin-strut cobalt-chromium open-cell stent architecture
- Delivery system: Rapid-exchange (monorail) balloon catheter
- Nominal diameter: 2.50 mm
- Nominal length: 18 mm
- Guidewire compatibility: 0.014 in
- Design intent: Abluminal-only coating to limit polymer exposure on the luminal surface
- Sterility: Supplied sterile, single-use
Clinical Applications
- Percutaneous coronary intervention in native coronary arteries
- Treatment of de novo coronary lesions in vessels matched to a 2.50 mm reference diameter
- Use in interventional cardiology procedures where a drug-eluting stent strategy is selected by the treating clinician
- Suitability for specific patient populations and lesion subsets must be determined per the official Instructions for Use
Product Information
- Brand: Terumo
- Product family: Ultimaster Nagomi
- Category: Coronary Stents
- REF / UPN: DE-RS2518ASM
- Size: 2.50 mm × 18 mm
- Drug coating: Sirolimus with bioresorbable polymer (abluminal)
- Delivery: Rapid-exchange PTCA-style catheter
- Packaging: Not specified in the located sources
- Shelf life and storage: Not specified in the located sources
- Regulatory status: Refer to local regulatory documentation and official Instructions for Use
Tell us what product you need and share a few details.
We connect your request with the most relevant verified brands.
Relevant supplier options can respond with availability, documentation context, and quote details.
Practical answers for procurement teams reviewing this product page.
Include the exact product family, brand preference, REF/UPN code when available, required quantity, destination country, expected delivery timing and documentation expectations.
Yes. If alternatives are acceptable, mention equivalent brands, compatible models, size ranges and any non-negotiable requirements.
Related products are connected through structured catalog data such as brand, category, product family and country assignment.
No. This page supports sourcing and RFQ organization. Buyers must verify regulatory status, clinical suitability and procurement compliance independently.
Specific codes reduce ambiguity and help supplier teams identify product availability, packaging details and documentation faster.
Yes. The workflow is designed for hospitals, clinics, distributors, wholesalers, importers and procurement departments.
Yes. Products can be connected to multiple countries in the admin panel, and buyers can specify destination details in the RFQ form.
The request is stored with contact and procurement details so the sourcing conversation can be reviewed and followed up clearly.